Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Philip Home, Sei Hyun Baik, Guillermo González Gálvez, Rachid Malek & Annie Nikolajsen. (2015) An analysis of the cost-effectiveness of starting insulin detemir in insulin-naïve people with type 2 diabetes. Journal of Medical Economics 18:3, pages 230-240.
Read now
Read now
Christopher Sorli & Michael K Heile. (2014) Identifying and meeting the challenges of insulin therapy in type 2 diabetes. Journal of Multidisciplinary Healthcare 7, pages 267-282.
Read now
Read now
Ning Wu, Mark Aagren, Luke Boulanger, Michelle Friedman & Kelly Wilkey. (2012) Assessing achievement and maintenance of glycemic control by patients initiating basal insulin. Current Medical Research and Opinion 28:10, pages 1647-1656.
Read now
Read now
Russell D. White. (2012) Patient empowerment and optimal glycemic control. Current Medical Research and Opinion 28:6, pages 979-989.
Read now
Read now
Bridget R Levich. (2011) Diabetes management: optimizing roles for nurses in insulin initiation. Journal of Multidisciplinary Healthcare 4, pages 15-24.
Read now
Read now
Scott E Nelson. (2011) Detemir as a once-daily basal insulin in type 2 diabetes. Clinical Pharmacology: Advances and Applications 3, pages 27-37.
Read now
Read now
Gabriele Perriello, Salvatore Caputo, Giovanni De Pergola, Alberto Di Carlo, Giorgio Grassi, Annunziata Lapolla, Pietro Pata, Sebastiano Bruno Solerte & Francesco Zaccardi. (2011) Improved glycemic control with weight loss and a low risk of hypoglycemia with insulin detemir: insights from the Italian cohort of the PREDICTIVE study after 6-month observation in type 2 diabetic subjects. Expert Opinion on Pharmacotherapy 12:16, pages 2449-2455.
Read now
Read now
Jean-Pierre Le Floch. (2010) Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics. Diabetes, Metabolic Syndrome and Obesity 3, pages 197-213.
Read now
Read now
Athena Philis-Tsimikas. (2008) Tolerability, safety and adherence to treatment with insulin detemir injection in the treatment of type 2 diabetes. Patient Preference and Adherence 2, pages 323-332.
Read now
Read now
E. S. Kilpatrick, A. K. Das, C. Ørskov & K. Berntorp. (2008) Good glycaemic control: an international perspective on bridging the gap between theory and practice in type 2 diabetes. Current Medical Research and Opinion 24:9, pages 2651-2661.
Read now
Read now
Articles from other publishers (19)
Mohammed E. Khamseh, Vinay Prusty, Zafar Latif, Guillermo Gonzalez-Galvez, Guillermo Dieuzeide & Alexey Zilov. (2014) Type 2 Diabetes Mellitus Management and Body Mass Index: Experiences with Initiating Insulin Detemir in the A1chieve Study. Diabetes Therapy 5:1, pages 127-140.
Crossref
Crossref
Alexey Zilov, Nabil El Naggar, Siddharth Shah, Chunduo Shen & Jihad Haddad. (2013) Insulin detemir in the management of type 2 diabetes in non-Western countries: Safety and effectiveness data from the A1chieve observational study. Diabetes Research and Clinical Practice 101:3, pages 317-325.
Crossref
Crossref
L A Ruiatkina & M Iu Sorokin. (2013) Detemir (Levemir): modern paradigms of insulin therapy. Problems of Endocrinology 59:4, pages 56-64.
Crossref
Crossref
Chirk Jenn Ng, Su May Liew, Shireene R Vethakkan, Adina Abdullah & Cheong Lieng Teng. (2013) Patient-adjusted versus health professional-adjusted insulin dosing for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Melanie DaviesSimon HellerSeamus Sreenan, Hélène Sapin, Omolara AdetunjiArash TahbazJiten Vora. (2013) Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir. Diabetes Care 36:5, pages 1368-1376.
Crossref
Crossref
Sara L. Ford & Heather Lynch. (2013) Practical Use of Home Blood Glucose Monitoring in Feline Diabetics. Veterinary Clinics of North America: Small Animal Practice 43:2, pages 283-301.
Crossref
Crossref
Kee-Ho SongJung Min KimJung-Hyun NohYongsoo ParkHyun-Shik SonKyong Wan MinKyung Soo Ko. (2013) Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study. Diabetes & Metabolism Journal 37:2, pages 117.
Crossref
Crossref
Gillian M. Keating. (2012) Insulin Detemir. Drugs 72:17, pages 2255-2287.
Crossref
Crossref
Luigi Meneghini, Andreas Liebl & Martin J. Abrahamson. (2010) Insulin detemir: A historical perspective on a modern basal insulin analogue. Primary Care Diabetes 4, pages S31-S42.
Crossref
Crossref
Martin J. Abrahamson. (2010) Basal insulins: Pharmacological properties and patient perspectives. Primary Care Diabetes 4, pages S19-S23.
Crossref
Crossref
Virginia Valentine. (2010) Insulin Initiation During a 20-Minute Office Visit: Part 2: Making It Happen. Diabetes Spectrum 23:4, pages 260-266.
Crossref
Crossref
Charmaine D. Rochester, Nicholas Leon, Robert Dombrowski & Stuart T. Haines. (2010) Collaborative drug therapy management for initiating and adjusting insulin therapy in patients with type 2 diabetes mellitus. American Journal of Health-System Pharmacy 67:1, pages 42-48.
Crossref
Crossref
Sanne G. SwinnenJoost B. HoekstraJ. Hans DeVries. (2009) Insulin Therapy for Type 2 Diabetes. Diabetes Care 32:suppl_2, pages S253-S259.
Crossref
Crossref
Scott Drab. (2009) Translating clinical guidelines into clinical practice: Role of the pharmacist in type 2 diabetes management. Journal of the American Pharmacists Association 49:6, pages e152-e162.
Crossref
Crossref
A. J. Garber. (2009) The importance of titrating starting insulin regimens in patients with type 2 diabetes. Diabetes, Obesity and Metabolism 11, pages 10-13.
Crossref
Crossref
Robert E. Rakel. (2009) Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy. Advances in Therapy 26:9, pages 838-846.
Crossref
Crossref
Kirsten Roomp & Jacquie Rand. (2009) Intensive Blood Glucose Control is Safe and Effective in Diabetic Cats Using Home Monitoring and Treatment with Glargine. Journal of Feline Medicine and Surgery 11:8, pages 668-682.
Crossref
Crossref
Mariëlle J. P. van Avendonk & Guy E. H. M Rutten. (2009) Insulin therapy in type 2 diabetes: what is the evidence?. Diabetes, Obesity and Metabolism 11:5, pages 415-432.
Crossref
Crossref
Luigi F Meneghini. (2008) Insulin detemir: a long-acting insulin analog for the treatment of Type 1 and 2 diabetes. Therapy 5:4, pages 513-529.
Crossref
Crossref